
CN Bio and Altis Biosystems have announced that they will enter a strategic partnership, through which Altis’ human RepliGut Planar-Jejunum …

On 30August 2023, CN Bio announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer (CSO) – a new …

CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), has received a grant from innovation agency Innovate …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

